An update on methotrexate pharmacogenetics in rheumatoid arthritis

Keyphrases

• Rheumatoid Arthritis 100%
• Pharmacogenetics 100%
• Methotrexate 100%
• Disease-modifying Antirheumatic Drugs (DMARDs) 60%
• Patient Response 40%
• Joint Damage 40%
• High Morbidity 20%
• High Mortality 20%
• Long-term Safety 20%
• Clinical Symptoms 20%
• Clinical Signs 20%
• Long-term Efficacy 20%
• Systemic Inflammatory Response Syndrome 20%
• Rheumatoid Arthritis Treatment 20%
• Disease Symptoms 20%
• Radiographic Progression 20%
• Methotrexate Treatment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Pharmacogenetics 100%
• Methotrexate 100%
• Inflammatory Arthritis 100%
• Disease Modifying Antirheumatic Drug 50%
• Diseases 50%
• Physical Disease by Body Function 16%